AN
Amphastar Nanjing Pharmaceuticals Inc (ANP)
Manufacturer · Nanjing, China
Overview
Amphastar Nanjing Pharmaceuticals is one of the subsidiaries where Amphastar Pharmaceuticals (NASDAQ: AMPH) develops and makes APIs, which include insulins, cosyntropin and vasopressin. Amphastar received US approval for a teriparatide injection in December 2025. ANP holds an active US Type II DMF for teriparatide.
Capabilities
- Teriparatide API
- Insulin APIs
- Peptide hormones
Quality signals
| GMP evidence | Not found |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |